This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Why it is time to think differently about Nasal delivery of Biologics
Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights, Brand Differentiation
Aptar Pharma discusses intranasal administration for CNS therapeutics
Webinars, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions, Drug Delivery Innovations
New solutions for pre-clinical discovery in respiratory healthcare
Webinars, Pharmaceutical, Drug Delivery Innovations, Market Insights, Product Solutions
Improving Intranasal Sprays for Respiratory Viral Infections
Publications, Pharmaceutical, Drug Delivery Innovations, Brand Differentiation, Product Solutions
